Literature DB >> 15855896

Breast cancer susceptibility and the DNA damage response.

Vesna Dapic1, Marcelo A Carvalho, Alvaro N A Monteiro.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15855896     DOI： 10.1177/107327480501200210

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  17 in total

1.  Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.

Authors:  Patricia Rodrigues; Jessica Furriol; Eduardo Tormo; Sandra Ballester; Ana Lluch; Pilar Eroles
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

2.  RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women.

Authors:  Ana M Krivokuca; Emina J Malisic; Jelena D Dobricic; Ksenija V Brotto; Milena R Cavic; Radmila N Jankovic; Zorica I Tomasevic; Mirjana V Brankovic-Magic
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 3.  Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Authors:  Katherine Stemke-Hale; Bryan Hennessy; Gordon B Mills; Rahul Mitra
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

4.  CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer.

Authors:  Lukasz Kruszyna; Margarita Lianeri; Błażej Rubis; Hanna Knuła; Maria Rybczyńska; Sylwia Grodecka-Gazdecka; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2010-06-20       Impact factor: 2.316

5.  A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.

Authors:  Yi Shi; Lin Sun; Ge Chen; Dongyan Zheng; Li Li; Wanguo Wei
Journal:  Target Oncol       Date:  2015-04-29       Impact factor: 4.493

6.  Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.

Authors:  Volga S Syamala; Vani Syamala; Hariharan Sreedharan; Praveenkumar B Raveendran; Ratheesan Kuttan; Ravindran Ankathil
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  PathCards: multi-source consolidation of human biological pathways.

Authors:  Frida Belinky; Noam Nativ; Gil Stelzer; Shahar Zimmerman; Tsippi Iny Stein; Marilyn Safran; Doron Lancet
Journal:  Database (Oxford)       Date:  2015-02-27       Impact factor: 3.451

8.  Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.

Authors:  João Conde; Susana N Silva; Ana P Azevedo; Valdemar Teixeira; Julieta Esperança Pina; José Rueff; Jorge F Gaspar
Journal:  BMC Cancer       Date:  2009-09-25       Impact factor: 4.430

9.  Patient interest in recording family histories of cancer via the Internet.

Authors:  Christian Simon; Louise Acheson; Christopher Burant; Nancy Gerson; Sarah Schramm; Susan Lewis; Georgia Wiesner
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

10.  Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.

Authors:  Sandra Costa; Daniela Pinto; Deolinda Pereira; Helena Rodrigues; Jorge Cameselle-Teijeiro; Rui Medeiros; Fernando Schmitt
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.